Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.42)
# 993
Out of 5,116 analysts
120
Total ratings
48.39%
Success rate
4.88%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $133.79 | +27.06% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $16.49 | +21.29% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $62.70 | +27.59% | 3 | Dec 22, 2025 | |
| QTRX Quanterix | Maintains: Hold | $5 → $8 | $6.46 | +23.84% | 8 | Dec 22, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $2 → $1.5 | $1.23 | +21.95% | 6 | Dec 22, 2025 | |
| NTRA Natera | Maintains: Buy | $250 → $285 | $233.74 | +21.93% | 12 | Dec 22, 2025 | |
| ILMN Illumina | Maintains: Hold | $112 → $130 | $134.95 | -3.67% | 14 | Dec 22, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $125 | $102.98 | +21.38% | 10 | Dec 22, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 → $50 | $39.40 | +26.92% | 6 | Dec 22, 2025 | |
| CAI Caris Life Sciences | Maintains: Hold | $28 → $30 | $28.24 | +6.25% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $101.57 | +3.38% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $105 | $91.59 | +14.64% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $42.49 | +1.20% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $166.21 | -0.73% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $6.13 | +144.70% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $6.76 | +195.81% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.77 | +69.49% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.09 | +175.23% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.25 | +700.00% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.29 | +16,906.57% | 1 | Mar 30, 2021 |
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $133.79
Upside: +27.06%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $16.49
Upside: +21.29%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $62.70
Upside: +27.59%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $6.46
Upside: +23.84%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2 → $1.5
Current: $1.23
Upside: +21.95%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $233.74
Upside: +21.93%
Illumina
Dec 22, 2025
Maintains: Hold
Price Target: $112 → $130
Current: $134.95
Upside: -3.67%
Guardant Health
Dec 22, 2025
Maintains: Buy
Price Target: $100 → $125
Current: $102.98
Upside: +21.38%
Castle Biosciences
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $39.40
Upside: +26.92%
Caris Life Sciences
Dec 22, 2025
Maintains: Hold
Price Target: $28 → $30
Current: $28.24
Upside: +6.25%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $101.57
Upside: +3.38%
Nov 17, 2025
Maintains: Buy
Price Target: $85 → $105
Current: $91.59
Upside: +14.64%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $42.49
Upside: +1.20%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $166.21
Upside: -0.73%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $6.13
Upside: +144.70%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $6.76
Upside: +195.81%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.77
Upside: +69.49%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.09
Upside: +175.23%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.25
Upside: +700.00%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.29
Upside: +16,906.57%